53.81
Pulse Biosciences Inc stock is traded at $53.81, with a volume of 367.60K.
It is up +7.66% in the last 24 hours and up +1.32% over the past month.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
See More
Previous Close:
$49.98
Open:
$49.98
24h Volume:
367.60K
Relative Volume:
0.83
Market Cap:
$3.84B
Revenue:
$751.00K
Net Income/Loss:
$-74.57M
P/E Ratio:
-48.78
EPS:
-1.1031
Net Cash Flow:
$-55.52M
1W Performance:
+6.55%
1M Performance:
+1.32%
6M Performance:
+188.22%
1Y Performance:
+205.74%
Pulse Biosciences Inc Stock (PLSE) Company Profile
Name
Pulse Biosciences Inc
Sector
Industry
Phone
510-906-4600
Address
3957 POINT EDEN WAY, HAYWARD, CA
Compare PLSE vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences Inc
|
53.81 | 3.84B | 751.00K | -74.57M | -55.52M | -1.1031 |
|
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-26 | Initiated | BTIG Research | Buy |
| Aug-17-26 | Initiated | Needham | Buy |
| Jun-04-26 | Initiated | Canaccord Genuity | Buy |
| Jan-30-26 | Initiated | Mizuho | Outperform |
| Jul-07-25 | Initiated | Oppenheimer | Outperform |
| Jul-27-21 | Initiated | Stephens | Overweight |
| Mar-11-21 | Initiated | Maxim Group | Buy |
| Jan-26-21 | Reiterated | H.C. Wainwright | Buy |
| May-12-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-14-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Feb-25-19 | Initiated | H.C. Wainwright | Buy |
View All
Pulse Biosciences Inc Stock (PLSE) Latest News
Pulse Biosciences: Promising Technology, But Hard To Justify Its Valuation (NASDAQ:PLSE) - Seeking Alpha
Pulse Biosciences Opens New $85 Million At-the-Market Stock Offering - Minichart
Form 8K Pulse Biosciences Inc For: 15 September By Investing.com - Investing.com Nigeria
Pulse Biosciences Launches New ATM Equity Program - TipRanks
Pulse Biosciences enters $85 million equity distribution agreement with Mizuho - Investing.com
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com India
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com Canada
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Nigeria
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Australia
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Nigeria
Why Pulse Biosciences Stock Popped Today - theglobeandmail.com
Why Pulse Biosciences Stock Popped Today - Yahoo Finance
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Australia
Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73 - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com India
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Canada
Pulse Biosciences stock hits all-time high at 56.15 USD - investing.com
$Pulse Biosciences (PLSE.US)$ the squeeze is onnnnnnnn - Moomoo
PLSE Initiates Coverage by Freedom Capital Markets -- Price Targ - GuruFocus
Freedom Capital initiates Pulse Biosciences stock with buy rating - investing.com
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Canada
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com UK
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Stock Price Forecast. Should You Buy PLSE? - StockInvest.us
Pulse Biosciences stock holds steady as investors eye recent clinical and financial progress - AD HOC NEWS
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Pulse Biosciences Inc (DE) (PLSE) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Nigeria
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com India
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com UK
COO pays nearly $50 a share for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
$Pulse Biosciences (PLSE.US)$ New ATH 🔥 - Moomoo
Pulse Biosciences Reports Teplitsky Liane Rae as New Insider COO - Kalkine Media
Pulse Biosciences stock hits new high as insider buying fuels rally - ad-hoc-news.de
Pulse Biosciences stock hits all-time high at 51.0 USD - Investing.com
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Canada
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com South Africa
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com India
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Nigeria
Pulse Biosciences (PLSE) Slips 2% as Shares Approach Key Support at $45.19IV Crush Alert - vinanet.vn
Pulse Biosciences (PLSE) Slips 2% as Shares Approach Key Support at $45.19Shakeout Pattern - dars.gov.et
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock By Investing.com - Investing.com Nigeria
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,965 in stock By Investing.com - Investing.com South Africa
Pulse Biosciences Inc Stock (PLSE) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pulse Biosciences Inc Stock (PLSE) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 31 '26 |
Buy |
48.80 |
1,024 |
49,971 |
3,094 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 28 '26 |
Buy |
48.35 |
1,034 |
49,994 |
2,070 |
| Teplitsky Liane Rae | Chief Operating Officer |
Aug 26 '26 |
Buy |
48.23 |
1,036 |
49,971 |
1,036 |
| DUGGAN ROBERT W | Director |
May 11 '26 |
Buy |
19.69 |
660,233 |
12,999,988 |
48,211,433 |
| LAVIOLETTE PAUL A | Chief Executive Officer |
May 11 '26 |
Buy |
19.69 |
15,000 |
295,350 |
15,000 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Option Exercise |
1.53 |
5,000 |
7,650 |
48,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 18 '26 |
Sale |
23.64 |
5,000 |
118,200 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 17 '26 |
Sale |
23.63 |
20,000 |
472,600 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 13 '26 |
Sale |
23.53 |
20,000 |
470,600 |
43,298 |
| Danahy Kevin Patrick | Chief Commercial Officer |
Feb 12 '26 |
Sale |
23.37 |
20,000 |
467,400 |
43,298 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):